Villers-lès-Nancy, 1st July 2025 – 07:00 p.m. (CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS’ MEETING
OF 25 JUNE 2025
Number of shares comprising the share capital: 15,174,125
Number of shares with voting rights: 14,830,415
Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,173,125
That means a quorum of 88.83% of the 14,830,415 shares with voting rights: the Ordinary Annual General Meeting was able to deliberate.
The Ordinary Annual General Meeting was held on Wednesday, 25 June 2025 at 5:30 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2024 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:
| Resolutions | Results of the votes |
Approval of the annual financial statements | Resolution adopted by:
|
Discharge of directors and discharge of the Statutory Auditors for the performance of their engagement | Resolution adopted by:
|
| Resolution adopted by:
|
Appropriation of earnings, setting the dividend | Resolution adopted by:
|
Agreements and commitments governed by Articles L. 225-38 of the French Commercial Code | Resolution adopted by (*):
|
Approval of the information on the compensation of corporate officers paid in or granted for fiscal 2024 and mentioned in Article L. 22-10-9 of the French Commercial Code | Resolution adopted by:
|
Approval of the components of compensation paid in 2024 to Mr. Thierry CHAPUSOT, Chairman of the Board of Directors | Resolution adopted by:
|
Approval of the components of compensation paid in 2024 to Mr. Denis SUPPLISSON, Chief Executive Officer | Resolution adopted by:
|
Approval of the components of compensation paid in 2024 to Mr. Grégoire DE ROTALIER, Deputy CEO | Resolution adopted by:
|
Approval of the components of compensation paid in 2024 to Mr. Damien VALICON, Deputy CEO (non-Board member), as from 01/04/2024 | Resolution adopted by:
|
Approval of the compensation policy for Mr. Thierry CHAPUSOT, Chairman of the Board of Directors, for 2025 | Resolution adopted by:
|
Approval of the compensation policy for Mr. Denis SUPPLISSON, Chief Executive Officer, for 2025 | Resolution adopted by:
|
Approval of the compensation policy for Mr. Grégoire de ROTALIER, Deputy Chief Executive Officer, for 2025 | Resolution adopted by:
|
Approval of the compensation policy for Mr. Damien VALICON, Deputy Chief Executive Officer, for 2025 | Resolution adopted by:
|
Approval of the compensation policy for Directors | Resolution adopted by:
|
Setting total annual compensation for Directors for 2025 | Resolution adopted by:
|
Authorisation by the Company to repurchase its own shares | Resolution adopted by:
|
Powers for formalities | Resolution adopted by:
|
(*) After deduction of excluded voting rights
Upcoming financial communications
- 31 July 2025: Q2 2025 revenue – After the close of trading
- 26 September 2025: H1 2025 results: 26 September 2025
About Equasens Group
Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.300 people across Europe.
Equasens Group’s specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as data hosting, financing and training adapted to their specific needs.
And reflecting the spirit of its tagline “Technology for a More Human Experience”, the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient and secure healthcare system.
Listed on Euronext Paris™ – Compartment B
Indexes: MSCI GLOBAL SMALL CAP – GAÏA Index 2020 – CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label
Eligible for the Deferred Settlement Service (“Service à Réglement Différé” – SRD) and equity savings accounts invested in small and mid-caps (PEA-PME).
ISIN: FR 0012882389 – Ticker Code: EQS
Get all the news about Equasens Group http://www.equasens.com and on LinkedIn
CONTACTS
EQUASENS Group
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 – frederique.schmidt@equasens.com
Financial communications agency:
FIN’EXTENSO – Isabelle Aprile
Tel.: +33 (0)6 17 38 61 78 – i.aprile@finextenso.fr
Attachment
